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Abstract 
Excessive growth of the arterial smooth muscle is essential for the development of atherosclerosis and leads to arterial insufficiency in 
several other conditions. It is therefore important o elucidate the mechanisms that regulate the growth of the human arterial 
smooth-muscle c ll, SMC. Like other untransformed cells, SMC require plasma for sustained growth in vitro. As found in an earlier study 
most of the material in plasma which stimulates SMC growth is related to the lipoproteins (LP), and is widespread among LP of different 
density classes. In the present study we investigated whether the growth-stimulating activity might be more specifically related to certain 
lipoproteins defined by criteria other than density or particle size. Activity was assayed using human SMC and human lung fibroblasts as 
both a change of culture size and DNA synthesis. The growth-stimulating activity was confined to apt B-containing LP, as defined by 
their strong affinity to heparin-Sepharose, electrophoretic t-mobility, the presence of apt B and the absolute requirement of low density 
lipoprotein (LDL) receptors ',for the growth-stimulating effect to appear. It was strongly potentiated by PDGF-BB. A much higher level of 
LDL was required to initiate synthesis of DNA in SMC than in fibroblasts but at optimal LDL concentration the degree of activation was 
similar for both cell types. Apt B-containing LP are very powerfully related to atherosclerosis. As intimal thickening is a primary change 
in atherogenesis, the growth-stimulating effect of them may be of direct pathogenetic importance. 
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1. Introduction 
The excessive proliferation of the smooth musculature 
in the arterial intima constitutes a central change in con- 
junction with the occun'ence of atherosclerosis [1] and 
plays an important role ir~t a number of non-atherosclerotic 
conditions, which lead to arterial insufficiency, such as 
restenosis following angioplasty [2], the neointimal occlu- 
sion of grafts and by-passes [3] and chronic vascular 
rejection after transplantation [4]. It is important to obtain 
an understanding of the factors which regulate the growth 
of the human arterial smooth-muscle c ll (SMC). Like 
other untransformed cells, SMC require components in 
plasma for sustained growth [5-8]. Most of the growth- 
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stimulating effect exerted by plasma on SMC and fibro- 
blasts is found in the lipoprotein fraction [8]. This activity 
is not linked to any class of lipoproteins defined specifi- 
cally by density or particle size but is distributed through- 
out most of the lipoprotein spectrum [8]. The growth- 
stimulating effect of lipoproteins i not dependent upon the 
supply of nutriments, cholesterol or essential fatty acids 
but appears more specific [8]. The non-specific distribution 
over most of the lipoprotein spectrum is surprising. The 
aim of this study was therefore to investigate whether 
growth-stimulating activity could be associated with 
lipoprotein properties other than density and particle size. 
The main finding of this study is that growth-stimulat- 
ing activity was confined to apt B-containing lipoproteins 
defined by their affinity to heparin-Sepharose, their elec- 
trophoretic pre-fl-and t-mobility, the presence of apolipo- 
protein-B and the absolute requirement of LDL receptors 
in the cells for the growth-stimulating effect o be seen. 
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2. Materials and Methods 
2.1. Chemicals 
Recombinant human platelet-derived growth factor, iso- 
form BB (PDGF-BB) and cholesterol (tissue culture grade) 
were purchased from Sigma. Other chemicals are specified 
in the description of the separate xperiments. 
2.2. Cell culture and assay of cell growth 
Human arterial tissue was obtained from abdominal 
aorta in conjunction with the nephrectomy of young, male 
kidney donors with fatal injuries. The isolation of inner 
media by microdissection in buffered tissue culture medium 
with the elimination of endothelium and connective tissue 
has been described in detail elsewhere [7,9-11]. In short, 
isolated arterial media was raised into primary culture. The 
cells were passaged by trypsinization. SMC were used 
between the 2nd and 6th passages. The smooth-muscle 
nature of the cultures was confirmed by their characteristic 
hill-and valley-like growth pattern and by the immuno- 
histochemical identification of a-smooth-muscle actin with 
a specific monoclonal antibody [12]. Ordinary LDL recep- 
tor-positive fibroblasts were human fetal lung fibroblasts 
(LuF; State Bacteriological Laboratory, Stockholm, Swe- 
den) and, for the present purpose, they were used up to the 
19th passage. Human LDL receptor-negative fibroblasts 
(GM 1915 C) were obtained from the Human Mutant Cell 
Repository (Camden, N J, USA) and were used up to the 
14th passage. 
For growth measurements, cells were detached by 
trypsinization and suspended in MCDB 104 with 2.6 mM 
of L-glutamine, 100 /zg of streptomycin, 100 units of 
penicillin and 3% platelet-poor plasma serum (PPPS) [13] 
and plated into multi-wells (96-well plates for tissue cul- 
ture; Falcon) that were coated with 15 /zg per cm 2 of 
fibronectin isolated from human plasma [14]. The number 
of cells plated was low enough to keep the cultures well 
under confluence during the experiment. In the case of 
SMC, 4000 cells were plated per well. The fibroblasts 
were smaller and 8000 cells were therefore plated per well 
to produce a cell density similar to that of SMC. After 24 
h, the PPPS-containing medium was changed to plasma- 
free medium and the cells were incubated for at least 72 h 
to obtain quiescence. For this purpose, Iscove's modified 
Dulbecco's medium (Gibco) was used to avoid copper and 
iron components with 2.6 mM of L-glutamine and 100 /xg 
of streptomycin, 100 U of penicillin, 10 p,g transferrin 
(Collaboratory Research) and 2.0 mg of ovalbumin (Grade 
V, Sigma) per ml. For the subsequent period of exposure 
to growth factors and samples, this medium was used with 
a reduction of ovalbumin to 1.8 mg per ml and with the 
addition of 5 /zg of cholesterol per ml (see below), 0.2 mg 
per ml of fatty-acid-free HSA (Sigma) to serve as a 
peroxyl radical trap, and, unless stated otherwise in the 
description of the separate xperiments, 1 /xM of insulin. 
Access to exogenous cholesterol is required for the 
optimum growth of certain cell types under cholesterol-and 
serum-free conditions [15,16] and the cells were therefore 
supplied with exogenous cholesterol during the period for 
growth assay. Cholesterol may acquire cytotoxic effects 
with storage [8,15] and we purified the cholesterol with 
intervals of some months using column chromatography 
on aluminium oxide (Merck, Darmstadt, Germany). The 
purified cholesterol was dissolved in toluene and kept 
under nitrogen in the cold and in darkness. Before being 
added to the culture medium, the toluene was evaporated 
under nitrogen and the cholesterol dissolved in 96% ethanol 
to a concentration of 1 mg per ml. A volume of this 
solution was added to the albumin-containing culture 
medium (see above) to yield a concentration of 5 #g of 
cholesterol per ml. 
In preliminary dose-response experiments on the cell- 
multiplication-stimulating effect of PDGF-BB, an increas- 
ing effect was seen up to just below 10 ng of PDGF-BB 
per ml. PDGF-BB was therefore used throughout the study 
at a final concentration of 10 ng per ml. 
Plasma serum and lipoprotein samples to be added to 
cultures were dialysed at 4°C against PBS (Dulbecco's 
PBS; deoxygenated with N2; for details see figure legends) 
in a Pierce microdialysis apparatus (Pierce) with which 
dialysis was completed within 2 h or in ordinary dialysis 
tubing (Spectrapore, cut-off 6,000-8,000) with which dial- 
ysis was completed in 8 h. In the case of fractions from 
separations on heparin-Sepharose, exhaustive dialysis was 
performed as described above but against saline with 0.4% 
sodium EDTA (pH 7.4) (to avoid phosphate precipitate 
with Mn2-; see below) which was finally changed to 
saline to remove the EDTA. 
The duration of the incubation of the cultures with the 
various samples for which the effect on growth measured 
as culture size (see below) was to be tested is given in the 
description of the respective xperiment. For studies of 
DNA replication, the cultures were incubated, unless stated 
otherwise, for 24 h with 5 /zCi of methyl-[3H]thymidine 
(NET-027, NEN, Dupont) added to each well, after which 
the cells were detached by trypsinization and loaded onto a 
glass filter using a cell harvester. The activity was mea- 
sured by liquid scintillation counting. 
The culture size was determined by measuring mito- 
chondrial activity with the MTT method as described in 
[17] by the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) to blue formazan 
product. In short, 25 /zl of a solution of MTT in PBS (5 
mg per ml) was added to each well culture and the cultures 
were incubated in 5% CO 2 in air at 37°C for 5 h. When 
MTT is reduced, it is converted to blue formazan crystals 
during incubation and after incubation these crystals were 
dissolved by adding 70 /zl of 13% SDS in 0.013 N 
hydrochloric acid during an additional incubation period of 
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16 h. The absorbency was read at 590 nm in an EIA 
multi-well photometer. Growth as measured by the MTT 
method was expressed as; the net increase in absorbency 
after the subtraction of the background absorbency of the 
growth-factor-free control group for groups without 
PDGF-BB and of the PDGF-BB control group for cultures 
with added PDGF-BB ~md expressed as 'MTT units'. 
Control experiments described in a previous report had 
shown that there was a direct and linear relationship 
between the number of cells and the MTT values [8]. 
2.3, Heparinase treatment of cells 
The treatment of cells with heparinase was essentially 
performed in the manner described by Ji et al. [18]. In 
short, the heparinase (Heparinase I, Sigma; cat.no. H 2519, 
63 U, 367 U per mg solid) was dissolved in sterile saline 
with 2% fatty-acid-free BSA (Sigma; cell culture tested, 
low endotoxin) to a stem solution. This solution was added 
to the cell culture medium (see above) to a final concentra- 
tion of 3 U of heparinase per ml. The cultures were 
incubated with this solution for 120 min at 37°C. The 
cultures were gently rinsed three times with ordinary cul- 
ture medium to eliminate the heparinase. 
2.4. Lipoprotein isolation and fractionation 
Blood was collected from healthy male donors after 12 
h of fasting. During collection the blood was gently mixed 
with the following additions and at the stated final concen- 
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Fig. 1. Separation of high-density lipoprotein (HDL) using chromatography on heparin-Sepharose and the effect of the different fractions on culture growth 
and the DNA replication of human arterial SMC and human lung fibroblasts. (a) Chromatography on heparin-Sepharose was performed as described in 
Section 2 and on a 7.5-ml colunm (0.79 cm 2 × 9.5 cm). HDL was isolated as described in Section 2 using density gradient ultracentrifugation a d a total of 
10.5 mg of protein was loaded ,3n the column. The washing buffer was 5 mM of Tris (pH 7.4), with 0.05 M of NaC1 and 0.025 M of MnCI 2. The column 
was eluted with a flow of 0.23 ml per minute with the same buffer with a stepwise increase in NaC1 but with the omission of MnC12 as indicated in the 
figure. Fractions were collected in 4-ml portions for the first 25 ml and then in 2-ml portions. The portions were pooled to fractions A-G for activity 
measurements as indicated in tl~e figure. (b) Effect on the growth of SMC by fractions isolated on heparin-Sepharose and unfractionated HDL after 5 days 
of exposure. Controls and groups A, B, and C had 4 cultures in each group, while the other groups had 8. (c) Effect of the fractions and unfraetionated 
HDL on the [3H]thymidine incorporation of human lung fibroblasts. After 24 h of exposure to the separated fractions, [3H]thymidine was added and the 
cultures were incubated for another period of 24 h. Each group contained 8 cultures. (d) Effect of the fractions and unfractionated HDL on the culture 
growth of human lung fibroblasts after 5 days of incubation. The groups contained 8 cultures except for C and D without PDGF-BB, which had 6, and 
groups B, C, D and E without PDGF-BB, which had 7, 7, 3, and 5 cultures respectively. PDGF-BB was added as indicated in the figures and to a final 
concentration f 10 ng per ml. 
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trations: EDTA (sodium salt), 3.2 mM; sodium azide, 
0.01%; gentamycin sulphate, 80 mg per litre; soy-bean 
trypsin inhibitor (STI), 85 mg per litre; aprotinin, 3 mg per 
litre. The blood was chilled on ice during and after collec- 
tion. Plasma was prepared by centrifugation at 3000 × g 
for 30 min at 4°C. The following inhibitors were added to 
the plasma to the stated final concentrations: benzamidine, 
1 mM; phenylmethylsulfonylfluoride (PMSF), 2 mM; pep- 
statin A, 0.1 /xM; butylated hydroxy toluene (BHT), 10 
/~M. Platelet-poor whole plasma (WP) for the isolation of 
lipoproteins was prepared by the centrifugation of the 
plasma at 22000 × g for 30 min at 10°C and the collection 
of the supematant. The lipoproteins were separated by 
density cushion ultracentrifugation f the platelet-poor 
a 
in,Ira* ~mm~~ ~.11m u v,m~ mmm 
lb ~ ab ~ so eo 7o w so 
i~ B ' C 'D " E " F 'O '  H 
Elutlon volume, ml, and pooled fracl~ons 
o w. 
oo ÷ 
._B  
=.,~ 
b 
8000-  
6000- 
4000- 
2000- 
[ ]  No PDGF 
[ ]  With PDGF m 
'z- 
.~ ÷ 
= 
()  
6 ~ 
A B C D E F G H Tot. ~ A B C D E F G H Tol. 
m LP Lp C 
§ GROUP °° GROUP 
Fraction 
dilution, x 
A B Stand. C D D E F F G H H 
60 3 150 50 2 20 40 4 120 60 
kD 
200 
116 
92 
66 
45 
apo-E 
31 
apo-A I 
21.5 
14.4 
d ..... . . . . .  ......... 
apo-C 
Fig. 2. Chromatography of total lipoproteins on heparin-Sepharose, effects of isolated fractions on the synthesis of DNA and culture growth of human lung 
fibroblasts and the distribution of apo-proteins in the different chromatographic fractions as demonstrated using SDS-PAGE. (a) The chromatography on 
heparin-Sepharose was performed as described in Section 2 and in the legend to Fig. 1. Total lipoproteins were isolated using ultracentrifugation with a 
density cushion and dialysed as described in Section 2 and a sample of 6.3 mg of protein was loaded on the column after the addition of MnCI 2. After 
washing with the equilibration buffer, the column was eluted with the same buffer (see legend to Fig. 1) with a stepwise increase in NaC1 but with the 
omission of MnCI 2 and the collected portions were pooled as indicated. (b) Effect on the synthesis of DNA in human lung fibroblasts of fractions from 
total lipoproteins i olated using chromatography on heparin-Sepharose. The fractions to be tested, unfractionated total LP and [3H]thymidine, were added 
to the cultures and 24 h later the cells were taken for activity measurements as described in Section 2. Each group contained 6 cultures. (c) Effect of the 
isolated fractions and unfractionated total LP on the growth of human lung fibroblasts during 3 days of incubation. Each group contained 6 cultures. (d) 
SDS-PAGE on ExcelGel, gradient 8-18 of LP fractions isolated as shown in (a) and with activity as shown in (b) and (c). The electrophoretic separations 
in different lanes are not quantitatively comparable as the fractions with high protein content (peaks; see (a)) were more diluted before electrophoresis than 
the fractions with low protein content for optimum sensitivity and resolution. Arrow = origin. 
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plasma (whole plasma; WP) essentially in the manner 
described by Rudel et al. [19] with slight modifications. A 
'mock' [20] plasma solution with the same background salt 
density as plasma (d = 1 .I)063) with the following compo- 
sition was prepared: 0.02 M phosphate buffer (pH 7.4) 
with 0.15 M of sodium chloride, 3 mM of EDTA, 10 /zM 
of BHT, 1 mM of benzamidine, 0.1 gram per litre of 
sodium azide and 80 mg per litre of gentamycin sulphate. 
The mock plasma was adjusted to a density of 1.225 by 
adding solid NaBr and 7.0 ml was pipetted into a Quick- 
Seal centrifuge tube for a Ti 50.2 angle-head rotor for a 
Beckman L 8 M ultracentrifuge. WP was adjusted to 
d = 1.27 by adding solid NaBr. The density-adjusted WP 
was left for 1 h in the cold during which a slight protein 
precipitate formed and the precipitate was eliminated as a 
sediment by centrifugation at 22 000 × g for 20 min at 
10°C. Thirty-two ml of the WP supernatant was gently 
submersed below the density-adjusted mock plasma solu- 
tion (d = 1.225) with a peristaltic pump. The tubes were 
centrifuged at 50000 rpm (302 000 × g-max) for 26 h at 
4°C with slow acceleration and deceleration. The lipopro- 
teins floated to the top of the tube and were collected by 
gentle suction into a syringe after puncturing the tube wall. 
The heavy bottom zone of the tube was collected as 
lipoprotein-depleted plasma and the intermediate zone was 
discarded. 
The lipoproteins were further fractionated according to 
density using density-gradient ul racentrifugation in a 41 
Ti swinging-out rotor at 41 000 rpm (288 000 × g-max) for 
24 h and at 4°C. The solutions for the different density 
layers in the gradients were prepared by adding NaBr to 
the above-mentioned mock plasma. The gradients were 
shaped by layering density cushions as described by Pitas 
and Mahley [21] to cover the density range 1.006-1.21. 
If they were not used within two days, total lipoproteins 
and lipoprotein fractions were stored at -135°C under 
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Fig. 3. Fractionation f total lipoproteins on heparin-Sepharose andseparation f the active fraction on lysine-Sepharose. (a) Chromatography on 
heparin-Sepharose wasperfornled as described in Section 2 and in the legends to Figs. 1 and 2 with minor changes in the elution schedule. (b) 
Chromatography on lysine-Sepharose f the active fraction from the heparin-Sepharose fractionation shown in (a). The chromatography was performed as
described inSection 2. The sligJat increase inabsorbency in the right part of the curve was due to the higher absorbency of the EACA-containing buffer. 
The portions contained in the htrge peak to the start of elution (arrow) were pooled as a 'flow-through' fraction, the portions from the start of elution 
(arrow) to the slight increase inabsorbency to the right of the curve were pooled as a 'middle portion' and the remaining portions in the last part of the 
curve as the 'retained' fraction. (c) Effect on the growth of human lung fibroblasts ofactive material isolated using heparin-Sepharose chromatography and 
fractionated on lysine-Sepharose. For designations of pooled fractions see (a) above. The cultures were incubated for 5 days with the material to be 
assayed. There were 8 cultures in each group except for the groups exposed to active material from the heparin-Sepharose separation that was used as 
starting material for the subsequent separation lysine-Sepharose ('unseparated') which had 4 cultures each. 
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nitrogen after cryopreservation as described by Rumsey et 
al. [22]. In short, 200/xl of a stem solution containing 50% 
sucrose (w/v) ,  150 /xM of NaC1 and 0.24 mM of sodium 
EDTA (pH 7.4), was added to 800 /zl of the sample and 
gently mixed. The solution (in a siliconized glass test tube) 
was gassed with oxygen-free Nz, oxygen-tightly closed, 
frozen at - 70°C and, when frozen, transferred to - 135°C. 
LDL was acetylated using the method described by Basu 
et al. [23]. Protein was measured using the method de- 
scribed by Lowry et al. [24] as modified by Maxwell and 
co-workers [25] with serum albumin as standard. 
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2.5. Affinity chromatography on heparin-Sepharose and 
lysine-Sepharose 
All manipulations of the lipoproteins were carried out at 
+ 4 -+ 6°C. Chromatography on heparin-Sepharose of to- 
tal lipoproteins and HDL was performed essentially in the 
manner described in [21,26,27]. Heparin-Sepharose CL-6B 
was obtained from Pharmacia LKB Biotechnology. The 
lipoprotein (LP) sample was dialysed in dialysis tubing 
(Spectrapore 6000-8000) against 5 mM of Tris (pH 7.4), 
with 0.05 M of NaCI, 10 /zM of BHT and 1 mM of 
benzamidine which had been gassed with nitrogen. The 
concentration of the sample was adjusted to 6-12 mg of 
protein per ml. The heparin-Sepharose column was equili- 
brated with the above-mentioned buffer solution. Before 
loading the sample, the column was equilibrated with 5 
mM of Tris (pH 7.4), with 0.05 M of NaCI, 10 /~M of 
BHT, 1 mM of benzamidine, 0.02% Na-azide and 0.025 M 
of MnC12. Immediately prior to loading the sample, solid 
MnCI 2 was added to the sample to a final concentration f 
25 mM. The sample was loaded on the column and was 
left overnight on the column for equilibration. The elution 
schedule varied slightly for different separations; details 
are given in figure legends. 
The chromatography of LP fractions on lysine-Sep- 
harose was performed with slight modifications as de- 
scribed by Scanu et al. for lipoprotein(a), Lp(a) [28]. The 
lysine-Sepharose was obtained from Pharmacia LKB Bio- 
technology and was packed to a 5.0 ml column (0.79 
cm z × 7.5 cm). The column was equilibrated with 0.01 M 
of phosphate buffer (pH 7.4), with 0.15 M of NaCI, 0.01% 
sodium azide and 0.01% sodium EDTA and the sample 
Fig. 4. Electrophoretic properties ofgrowth-stimulating lipoprotein mate- 
rial isolated using heparin-Sepharose chromatography. (a) Total serum 
lipoproteins were fractionated using heparin-Sepharose chromatography 
as described in Section 2 and in Figs. 1 and 2. A 53-ml column (5.3 
cm 2 x 10 cm) was used and the elution schedule corresponded to that 
shown in Fig. 3a. One peak appeared asflow-through during washing and 
two appeared successively after stepwise elution (peaks 2and 3; see Fig. 
3a). The last of the peaks was divided at an inflection i to two subfrac- 
tions (3a and b). Peaks 2 and 3a and 3b were assayed for growth-stimulat- 
ing activity using the MTT method and compared with that of the 
unfractionated starting material (see (a)). The cultures were incubated for 
three days with the samples. All the groups contained 8 cultures. (b) 
Agarose lectrophoresis of fractions from the separation f total ipopro- 
teins using heparin-Sepharose chromatography as described in (a). The 
samples were run on the gel shown to the right and were unseparated 
total ipoproteins, peak 2, peak 3a and peak 3b. An identical separation is 
shown in the separate gel to the left, but for purposes ofcomparison, of 
sera from patients with high levels of Lp(a) (WBS I and V) and with high 
pre-fl-lipoprotein (WBS IV and V). Note that neither the unseparated 
total ipoproteins or the fractions shown to the right contained Lp(a). (c) 
SDS-PAGE on PhastGel gradient 4-15 of (from left to right) mixture of 
standards, unseparated total ipoproteins, peak 2, peak 3a and peak 3b. 
The samples were not lipid-extracted. Note that he growth-stimulating 
activity, as shown in (a), is virtually confined to apo B-containing 
fractions. 
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was dialysed against the same solution. The sample was 
loaded on the column and the column was washed with the 
same buffer solution unti;l the absorbency returned to the 
basal value (about 7 column volumes). The column was 
then eluted with the equilibration buffer to which 200 mM 
of e-aminocaproic acid (EACA) was added. 
2.6. Electrophoresis 
PAGE was performed for large size gels using the 
horizontal Multiphor II system or with mini-gels using the 
Phast-System (Pharmacia LKB Biotechnology, Bromma, 
Sweden) and as recommended by Pharmacia LKB for 
these systems. In the case: of SDS-PAGE on large gels on 
Multiphor II, precast 8-18% gradient, 0.5-mm thick, 
SDS-PAGE gels were used with buffer strips as the source 
of discontinuous buffer system (ExcelGels SDS, gradient 
8-18 and buffer strips; Pharmacia LKB Biotechnology, 
Bromma, Sweden). In the case of SDS-PAGE on mini-gels, 
precast PhastGel gradient 4-15 were used. The gels were 
silver-stained using proce,rlures slightly modified from that 
described by Heukeshoven and Dernick [29] and as recom- 
mended by the manufacturer of the gels. 
Electrophoresis on agarose of plasma and lipoproteins 
was performed with a kit for agarose gel electrophoresis 
designed for screening of Lp(a) for diagnostic determina- 
tion of lipoproteins (Hydragel LIPO + Lp(a); Sebia, Issy- 
les-Moulineaux, France) and used under the conditions 
recommended by the manufacturer for the resolution of/3-,  
pre-/3-, and c~-lipoproteim; and of Lp(a). Apo B and apo AI 
were measured with rocket immunoelectrophoresis. 
3. Results 
In a recent report we demonstrated that most of the 
growth-stimulating activity of human plasma serum was 
found in the lipoprotein fraction [8]. This activity was not 
confined to any specific lipoprotein class as defined ac- 
cording to density or particle size. We therefore attempted 
to isolate the growth-stimulating activity using other physi- 
cal methods. Fig. 1 shows the fractionation of HDL using 
chromatography on heparin-Sepharose and the distribution 
of the growth-stimulating activity for arterial SMC (Fig. 
lb) and lung fibroblasts (Fig. lc,d) as compared to the 
unfractionated starting material. The stimulating activity 
was confined to the peak with the strongest retention on 
the column and the activity increased significantly in the 
presence of PDGF-BB. The fractions with less or no 
affinity to the heparin-Sepharose displayed a varying de- 
gree of cytotoxicity. 
The results described above suggested that the activity 
of the unfractionated HDL might not belong to the HDL 
proper but to other lipoprotein material and similar frac- 
tionations were therefore performed on total lipoproteins, 
an example of which is shown in Fig. 2a. When it came to 
the HDL shown in Fig. 1, the activity of the total proteins 
was confined to the peak with the highest affinity to the 
heparin-Sepharose evaluated as the effect on both DNA 
synthesis (Fig. 2b) and culture growth (Fig. 2c). In the case 
of the HDL, material with a weaker affinity had cytotoxic 
effects. The proteins of the fractions were studied with 
SDS-PAGE (Fig. 2d). The active peak was made up 
exclusively of very high molecular weight material such as 
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Fig. 5. Effects of LDL and of total ipoproteins on DNA synthesis for fibroblasts with and without LDL receptors. (a) Stimulation ofDNA synthesis inthe 
absence of PDGF-BB. As indicated in the figure, the final concentrations of LDL and total lipoproteins were multiples of LDL and total lipoproteins 
containing 140 and 112 /zg of apo B per ml of incubation medium, respectively. The LDL material used was taken from the part of the gradient with 
density 1.063. The apo AI content in the total ipoproteins and the LDL fraction was 59% and 0.4%, respectively, of that of apo-B in these fractions. All 
the groups contained 8 cultures. The values have been ormalized tothe growth-factor-free controls and the absolute values for the controls were 550 5:38 
and 2386 -I- 152 cpm per well (rlean _ S.E.M.) for LDL receptor-free and LDL receptor-bearing fibroblasts respectively. (b) Stimulation ofDNA synthesis 
in the presence of PDGF-BB (10 ng per ml final concentration). The experimental conditions were identical to those for the experiment shown in (a) and 
the two experiments were carried out in parallel. The absolute values for the controls exposed exclusively to PDGF-BB were 2627 5:105 and 8195 5:375 
cpm per well (mean + S.E.M.) for LDL receptor-free and LDL receptor-bearing fibroblasts respectively. 
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apo B or apo(a). Apo E was confined to the second peak 
(D) which did not contain growth-stimulating material. 
In order further to investigate whether the growth- 
stimulating activity could be related to the presence of 
lipoprotein(a), active material was isolated using chro- 
matography on heparin-Sepharose (Fig. 3 3a) and sub- 
jected to affinity chromatography on lysine-Sepharose (Fig. 
3b). The growth-stimulating material was not retained by 
lysine-Sepharose (Fig. 3c), thereby indicating that it was 
not due to lipoprotein(a). 
For the additional electrophoretic characterization f the 
growth-stimulating material, isolation was performed on a 
larger scale with heparin-Sepharose. After assaying the 
growth-stimulating activity (Fig. 4a), inactive and two 
subfractions of active material were characterized elec- 
trophoretically. Electrophoresis was performed on agarose 
with a system designed to resolve ~-, /3-, pre-/3-1ipopro- 
teins and lipoprotein(a) (Fig. 4b). The active fractions were 
composed of lipoproteins with /3- and pre-/3-mobility, 
while the inactive fraction had a-mobility with a trace of 
material migrating as the active fractions. No material with 
mobility like that of lipoprotein(a) was found. SDS-PAGE 
on PhastGel gradient 4-15 (Fig. 4c) revealed the presence 
of very high molecular weight material indicative of apo B 
or apo(a) only in the active fraction. 
We investigated the importance of apo B in terms of the 
growth-stimulating effect by comparing its effect on fib- 
roblasts with and without LDL receptors (Fig. 5). The 
active material had no effect on the LDL receptor-negative 
fibroblasts (Fig. 5a) in the absence of PDGF-BB. Taken 
together with the absence of apo E in the active fractions 
(see Fig. 2d), this indicates that the growth-stimulating 
effect was due to apo B or to material bound to apo B. In 
the presence of PDGF-BB there was some stimulation of 
DNA synthesis even in the case of the LDL receptor-nega- 
tive fibroblasts (Fig. 5b), but the level was less than 
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Fig. 6. Influence of  treatment of  human lung fibroblasts with heparinase 
(see Section 2) on the stimulating effect of total lipoproteins on DNA 
synthesis with and without PDGF-BB. All the groups contained 8 cultures 
and total lipoproteins were added to a final concentration of 100 /zg of 
protein per ml and PDGF-BB to 10 ng per ml as indicated in the figures. 
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Fig. 7. Effect on the synthesis of DNA of increasing concentrations of 
LDL for fibroblasts (a) and SMC (b). (a) Dose-response curve for 
fibroblasts. Plating, cultivation, and harvesting of the cultures was done in 
96-well plate and as described in Section 2. At the highest concentration 
of LDL scattered retracted cells in the cultures indicated cytotoxic effects. 
Each group contained 6 cultures. The arrow and bar indicates values 
(mean + S.E.M.) for control group without LDL. (b) The effect of increas- 
ing concentration f LDL for SMC was measured as described in Fig. 7a 
and in Section 2. Signs of cytotoxicity appeared in cultures with the 
highest concentration f LDL. Data in (a) and (b) are from one represen- 
tative experiment of three with essentially identical results. The cultures 
were not exposed to insulin. Fibroblast and SMC cultures were incubated 
with LDL for 24 and 40 h, respectively. 
one-third of that for the receptor-positive c lls (Fig. 5b, 
legend). 
It is possible that compounds like LDL [30] with a high 
affinity for heparin-like substances might displace growth 
factors, like PDGF-BB or fibroblast growth factors, re- 
tained by heparin-like material [31,32], such as heparan 
sulfate, in the intercellular matrix and thereby indirectly 
have a growth-stimulating effect. To test this hypothesis, 
we compared the effects of total lipoproteins on the DNA 
synthesis of heparinase-treated an  untreated human lung 
fibroblasts. The heparinase treatment had no effect (Fig. 6) 
and this does not support he hypothesis that an indirect 
mechanism is responsible for the growth-stimulating ef- 
fects of lipoproteins. 
Dose-response experiments were carried out with in- 
creasing concentrations of LDL (Fig. 7). For fibroblasts, 
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stimulation of DNA synthesis occurred at a very low 
concentration (Fig. 7a). The curve levelled off from an 
LDL concentration of ca. 40 /xg of apo B per ml, indicat- 
ing saturation. The SMC were much less sensitive for 
activation by LDL and distinct stimulation of DNA synthe- 
sis appeared at a ca. 90 times higher concentration of LDL 
than for the fibroblasts. The maximal degree of stimulation 
was similar for both cell types at the optimal LDL concen- 
trations. At the highest LDL concentration, scattered re- 
tracted cells appeared in the cultures of both cell types, 
indicating cytotoxic effects. 
4. Discussion 
It is a well-known fact that there are a number of 
soluble components in plasma which have a growth- 
stimulating effect on cells. In this context, the effect of the 
particular plasma component, lipoproteins, is less well- 
known. There are, however, several reports on the effects 
exerted by lipoproteins on cells, but the results are incon- 
sistent and are, in fact, even contradictory in some cases. 
Most of the studies have not been conducted under totally 
serum-free conditions, thereby making their interpretation 
more difficult. Moreover, the degree to which the lipopro- 
teins have been shielded from proteolytic effects and oxi- 
dation during preparation and during incubation with cells 
is not clear in the majority of cases (for a more detailed 
discussion of earlier studies see Ref. [8]). 
In a previous study we investigated the distribution of 
the growth-stimulating activity in human plasma serum 
and found that 80% of this activity was confined to the 
lipoprotein fraction [8]. The activity was not linked to any 
specific class of lipoprotein, as defined by density proper- 
ties or particle size, but was instead spread over a large 
part of the lipoprotein spectrum. 
As we found no evidence to suggest hat the growth- 
stimulating effect of lipoproteins was dependent on the 
supply of nutrition factors such as cholesterol or fatty acids 
but was instead more spe, cific, the unspecific distribution 
of the activity was surprising. As a result, the present 
investigation was designed to see whether this activity 
could have some connection with lipoprotein character- 
istics other than density and particle size. 
We have also investigated the effect of PDGF-BB and 
the combined effects of ilipoprotein fractions and PDGF- 
BB. The rationale for this was the following. PDGF-BB is 
the very strong mitogenic component of human whole 
serum, and derived from the cellular part of the blood. 
According to a previous tudy [8], 80% of the platelet-free 
plasma-derived mitogenic activity was present in the lipo- 
proteins. It seems, therefore as PDGF-BB and lipoproteins 
constitute the two strongest mitogenic omponents of hu- 
man whole serum and we included PDGF-BB in parallel 
experiments to compare roughly the growth-stimulating 
capacity of the plasma, i.e., of the lipoproteins, and that of 
the platelet-derived serum mitogen, i.e., PDGF-BB, and to 
see if these activities were synergistic. The results of the 
present study show that the growth-promoting effect of the 
apo B-containing lipoproteins are considerable and similar 
to and in some experiments even larger than that of 
PDGF-BB and that their effects on growth are synergistic. 
The results also indicate an absolute requirement for LDL 
receptors for the growth-stimulating effect to occur. It is 
known that LDL receptor synthesis and activity is regu- 
lated not only by the intercellular pool of cholesterol but 
also by changes related to growth activation initiated by, 
e.g., PDGF (for review see Ref. [33]). 
Chromatography on heparin-Sepharose produces ome 
separation of the lipoproteins in terms of apoproteins [27]. 
Lipoproteins with apo E or apo B can be distinguished 
from one another and from other lipoproteins by their 
varying affinity to heparin-Sepharose. During the fraction- 
ation of HDL and total lipoproteins, the growth-stimulating 
activity in lipoproteins displayed the most powerful affin- 
ity to heparin-Sepharose; in other words, in a fraction in 
which previous investigations have revealed LDL and 
possibly Lp(a) [27]. The active material displayed /3-and 
pre-/3-mobility during electrophoresis on agarose, thereby 
confirming that apo B containing lipoproteins, i.e., LDL 
and VLDL, were involved. No Lp(a) was demonstrated 
during electrophoresis on agarose, nor could the active 
material be linked to lysine-Sepharose. These two findings 
indicated that Lp(a) could not be responsible for the 
activity. The indication that this activity is linked to LDL 
and VLDL was further supported in conjunction with 
SDS-PAGE. High molecular material, clearly indicative of 
apo B100, was found in the active fraction and only there. 
We finally found that the occurrence of LDL receptors 
on cells was an absolute requirement for the growth- 
stimulating effect of lipoproteins to be produced. Together 
with other findings, this demonstrated that apo B-contain- 
ing lipoprotein of the LDL and VLDL type is the growth- 
stimulating component of lipoproteins. It is not clear which 
component of these lipoproteins are responsible, but in a 
previous study we were able to demonstrate that growth 
stimulation was a more specific effect than the simple 
supply of nutriments or cholesterol and essential fatty 
acids [8]. 
Our experiments on the requirement for LDL receptors 
were carried out on LDL receptor-free fibroblasts. Ikeda 
and collaborators [34] have presented ata from studies on 
LDL receptor-free SMC from Watanabe heritable hyper- 
lipidemic rabbits which indicate that LDL receptors also 
were involved in proliferation of SMC. Even though the 
production of second messengers by mediation of the LDL 
receptor is well documented (for review see [33]) it should 
be pointed out that LDL may influence cells by other 
routes than the classical LDL receptor. Data have been 
presented suggesting that LDL bound by low affinity sites 
may induce signal transduction mediated by certain second 
messengers [35]. 
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It is known that the heparin-like component of the 
intercellular matrix, heparan sulfate, is able to bind growth 
factors like fibroblast growth factors and PDGF [32]. It is 
possible that material with a very strong affinity to heparin 
and heparan sulfate, like LDL [30], could perhaps exclude 
growth factors of this kind from the matrix and thereby 
indirectly trigger a growth-stimulating effect. In order to 
determine whether a mechanism of this type could cause 
the growth-stimulating effect of lipoproteins in our system, 
we exposed heparinase-treated an  untreated cells to lipo- 
proteins and compared the effect on DNA synthesis. We 
found no difference which contradicts the hypothesis that 
the growth-stimulating effect of the lipoproteins we stud- 
ied was caused by an indirect mechanism of this type. A 
direct effect from the lipoproteins is also supported by the 
fact that the occurrence of LDL receptors was an absolute 
prerequisite for the effect to be seen (see above). 
Fractions with a weaker affinity to heparin-Sepharose 
produced cytotoxic effects of varying degree. The cytotox- 
icity of lipoproteins is well-known from many previous 
studies [8,36-38] and can occur as a result of the oxidation 
of LDL. The risk of cytotoxicity can be reduced by 
protecting the LDL during isolation [39,40]. In a previous 
study we systematically examined ifferent altematives for 
isolating LDL and studied the incubation conditions in 
order to minimise the risk of LDL oxidation [8]. All the 
necessary steps were also taken to prevent LDL oxidation 
in the present study (see Section 2). It is therefore not 
feasible to cite oxLDL as the only cause of cytotoxicity in 
the present study. Another hypothetical possibility is that 
the harmful effects of certain lipoproteins are neutralised 
by other lipoproteins in mixtures but appear after isolation. 
One mechanism of this kind is known, namely, the protec- 
tive effect of HDL on the oxidation of LDL [36,41,42]. 
This protective ffect could also explain the somewhat 
surprising finding that the growth-stimulating activity in 
the HDL isolated using density gradient ultracentrifugation 
was linked not to HDL proper but clearly to the LDL 
impurity which was revealed uring the chromatographic 
fractionation on heparin-Sepharose. A number of previous 
studies have found a growth-stimulating effect produced 
by the HDL fraction of lipoproteins [37,39,43]. In contrast, 
HDL did not stimulate growth in several other studies 
[36,44,45]. It is possible that this discrepancy could be due 
to differences in the composition of the HDL preparations, 
when it comes to the occurrence of LDL, for example. 
LDL of this kind could have been shielded from oxidation 
by HDL and thereby maintained their growth-stimulating 
effect, unlike the less well protected main fraction of LDL 
where oxidation could have taken place more easily. 
Protection of LDL from oxidation by HDL [36,41,42] 
may also explain why total lipoproteins ometimes dis- 
played a stronger growth-promoting effect than LDL (Fig. 
5). This is strengthened by the finding that pretreatment of 
similar cultures with Probucol before incubation with LDL 
increased the growth-promoting effect of LDL at high 
LDL concentrations (Bj/Srkerud and Bj~Srkerud, unpub- 
lished). This indicates that in spite of the copper-and 
iron-free incubation medium used and the presence of 
albumin as a peroxyl scavenger, some oxidation of LDL 
occurred during incubation with LDL at high concentra- 
tions. This complies with protection of LDL by the HDL 
component as a reason for the strong growth-promoting 
effect of total lipoproteins. 
Dose-response experiments were carried out with in- 
creasing concentrations of LDL. For fibroblasts DNA syn- 
thesis was stimulated at very low concentrations of LDL 
(nanogram of apo B per ml level). The effect increased 
with increasing concentration and levelled off from ca. 40 
/zg of apo B per ml, indicating saturation. For SMC the 
sensitivity for LDL was much lower than for the fibro- 
blasts at low LDL concentrations. SMC required a ca. 90 
times higher LDL concentration for a clear stimulating 
effect on the synthesis of DNA. Considering the particu- 
larly exposed position of SMC for contact with plasma 
lipoproteins in vivo, it is possible that the high threshold 
for mitogenic stimulation for SMC may provide a safety 
mechanism against futile growth due to incidental expo- 
sure to low concentrations of LDL. The difference between 
the cell types decreased with increasing concentration of 
LDL and at the optimal LDL level for each cell type the 
degree of stimulation was about equal (see Fig. 7). Al- 
though there was a tendency for levelling off, saturation 
was not evident for SMC. This may be due to the lower 
sensitivity for the growth-stimulating effect of LDL and a 
higher sensitivity of these cells for the cytotoxic effects of 
LDL at very high concentrations. 
More than 95% of apo B-containing lipoproteins in the 
interstitial fluid in man have the density characteristics of
plasma LDL [46]. The level of apo B-containing lipopro- 
teins in the interstitial fluid in man corresponds to ca. 
100-150 /zg of apo B per ml [47]. This concentration 
coincides with the range for maximal stimulation in vitro 
in the present study for both fibroblasts and SMC. This 
might be taken to suggest hat these cells would be mito- 
genically stimulated by lipoproteins in the integrated tissue 
under ordinary conditions. However, the effective LDL 
concentration close to the cells would be much lower 
because direct contact between cells and particulate com- 
ponents of the interstitial fluid is impeded by sieving and 
exclusion by extracellular matrix components as, e.g., 
proteoglycans. For the arterial wall this is corroborated by 
studies with immunohistochemical l beling that showed 
minimal amounts of apo B in the smooth muscle tissue in 
the normal artery [48,49]. In contrast, after arterial injury 
by ballooning [48] and in human atherosclerotic lesions 
[49], apo B-containing LP were abundant both extracellu- 
larly and in cells. 
Low-density lipoprotein, and very-low-density lipopro- 
teins, are strongly linked with the occurrence of athero- 
sclerosis from an epidemiological, biochemical, and exper- 
imental angle [50-53]. LDL may also predispose to 
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restenosis following endarterectomy [54]. It is therefore 
very interesting that these,, lipoproteins are responsible for 
the growth-stimulating effect of lipoproteins. As excessive 
intimal thickening is one of the cardinal changes in the 
development of atherosclerosis and can lead to restenosis, 
the growth-stimulating effect of these lipoproteins could be 
of direct pathogenetic significance. However, it is also 
possible that growth stimulation which is balanced within 
physiological limits could be an important positive factor 
in the healing of arterial damage and wounds. 
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